[
    {
        "title": "Bohula E, Giugliano R, Ruff C, et al. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial. Circulation 2016; 134: 24\u201036.",
        "paper_uid": "c0f8d542",
        "pmid": "27358434",
        "reference": "Bohula E, Giugliano R, Ruff C, et al. Impact of Renal Function on Outcomes With Edoxaban in the ENGAGE AF-TIMI 48 Trial. Circulation 2016; 134: 24\u201036.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    },
    {
        "title": "Fox KA, Piccini JP, Wojdyla D, et al. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J 2011; 32: 2387-2394.",
        "paper_uid": "1cd94b34",
        "pmid": "21873708",
        "reference": "Fox KA, Piccini JP, Wojdyla D, et al. Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment. Eur Heart J 2011; 32: 2387-2394.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    },
    {
        "title": "Stanifer J, Pokorney S, Chertow G, et al. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease. Circulation 2020; 141: 1384\u20101392.",
        "paper_uid": "e3444fca",
        "pmid": "32160801",
        "reference": "Stanifer J, Pokorney S, Chertow G, et al. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease. Circulation 2020; 141: 1384\u20101392.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    },
    {
        "title": "Chashkina MI, Andreev DA, Kozlovskaya NL, et al. [Safety performance of rivaroxaban versus warfarin in patients with atrial fibrillation and advanced chro-nic kidney disease]. Kardiologiia 2020; 60: 1322.",
        "paper_uid": "bc897c67",
        "pmid": "33487155",
        "reference": "Chashkina MI, Andreev DA, Kozlovskaya NL, et al. [Safety performance of rivaroxaban versus warfarin in patients with atrial fibrillation and advanced chro-nic kidney disease]. Kardiologiia 2020; 60: 1322.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    },
    {
        "title": "Hori M, Matsumoto M, Tanahashi N, et al. Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. Circ J 2013; 77: 632-638.",
        "paper_uid": "54a711dd",
        "pmid": "23229461",
        "reference": "Hori M, Matsumoto M, Tanahashi N, et al. Safety and efficacy of adjusted dose of rivaroxaban in Japanese patients with non-valvular atrial fibrillation: subanalysis of J-ROCKET AF for patients with moderate renal impairment. Circ J 2013; 77: 632-638.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    },
    {
        "title": "Hijazi Z, Alexander JH, Li Z, et al. Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention Insights From the AUGUSTUS Trial. Circulation 2021; 143: 1215-1223.",
        "paper_uid": "e152d0a8",
        "pmid": "33461308",
        "reference": "Hijazi Z, Alexander JH, Li Z, et al. Apixaban or Vitamin K Antagonists and Aspirin or Placebo According to Kidney Function in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention Insights From the AUGUSTUS Trial. Circulation 2021; 143: 1215-1223.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    },
    {
        "title": "Hijazi Z, Hohnloser SH, Oldgren J, et al. Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time\u2014A RE-LY trial analysis. American Heart Journal 2018; 198: 169-177.",
        "paper_uid": "24f8f876",
        "pmid": "29653640",
        "reference": "Hijazi Z, Hohnloser SH, Oldgren J, et al. Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time\u2014A RE-LY trial analysis. American Heart Journal 2018; 198: 169-177.",
        "save_folder_path": null,
        "study_design": "Randomized Controlled Trial"
    }
]